Method of inducing production of IL-8 or TNF by in vitro administration of an N-terminal polypeptide of p43
US7037505B2 · kind B2 · utility
26Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2004 |
| Grant date | May 2, 2006 |
| Priority date | — |
| Expiry date | Jul 5, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an immunological enhancement agent, more particularly, to an immunological enhancement agent comprising peptide having an amino acid sequence represented by SEQ ID NO:1 to SEQ ID NO:3 as an effective component.The peptides according to the present invention comprising the N-terminal domain of the p43 protein have excellent cytokine activity to improve an immune response so that they can be used as an effective immunological enhancement agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.